jump to navigation

Medical and aesthetic laser devices provider Lumenis raised $15 Million July 3, 2009

Posted by israelhealthcare in Medical Aesthetics Device.
Tags: , ,
1 comment so far

Medical and aesthetic laser devices provider Lumenis has completed $15 million equity financing. Agate Medical Investments, a new investor, led the round with $5 million investment, together with two existing shareholders LM Partners LP and Ofer Hi-Tech.

The company also completed a restructuring of its bank debt allowing for a convenient loan repayment plan spread over 8 years until 2017.

“These additional cash resources will facilitate our investment in the future of our business, including potential strategic investments, acquisitions and other initiatives enabling us to maintain and enhance our leading industry position in all the markets in which we serve,” said Lumenis’ Chief Executive Officer, Dov Ofer.

Lumenis, a provider of laser, light-based and radio-frequency devices for surgical, aesthetic and ophthalmic applications, is Israel’s largest medical device company with more than 700 employees worldwide. The company Headquarters and R&D center are located in Yokneam, Israel.

Sponsored Links – Compression Boots for DVT Treatment | Olive Oil for Dehydrated Skin

Medical aesthetics device company Applisonix has raised $4.5 million August 2, 2006

Posted by israelhealthcare in Medical Aesthetics Device.
add a comment

Medical aesthetics device company Applisonix has raised $4.5 million in investment round led by Infinity Venture Capital. Other investors include Infinity’s technology incubator Maayan Ventures, Magari Limited, Cyventure Capital and Athena Cyprus, which is part of the Cyprus Funds and Kanit Group.

The financing is earmarked to support the continuation of product development and the commencement of clinical trials. Applisonix focused on developing and marketing a breakthrough hair removal solution utilizing ultrasound (HIFU) technology.

Applisonix’s technology offers an easy and painless means to get rid of unwanted hair for a long period. It doesn’t burn the skin and works with all hair and skin pigment types. The global hair-removal market is estimated at more $5 billion.

Sponsored Links – Health Care Applications Testing | Elderly Medical Alert System

TA Associates invest $90 Million in aesthetic devices provider Alma Lasers March 24, 2006

Posted by israelhealthcare in Medical Aesthetics Device.
add a comment

Private equity and buyout firm TA Associates has completed a $90 million investment in Alma Lasers, a provider of laser devices for aesthetic, medical and dental applications. Alma Lasers resulted from the merger of two laser companies, MSQ, founded by industry veteran laser physicist Ziv Karni, Ph.D., and Orion Lasers, a U.S. based laser distributor.

The aesthetic medical device market is large, growing and very profitable. The global aesthetic laser market is estimated at over $1 billion globally and is growing at over 20% annually. Israel is the home for the dominant players in this high growth market including, Syneron, Lumenis, Radiancy and Alma Lasers.

Alma Lasers is a developer, manufacturer and marketer of laser, light and radiofrequency-based systems for the aesthetic medical market. Alma Lasers’ products are used for non-invasive aesthetic procedures such as hair removal, skin rejuvenation and cellulite reduction on an outpatient basis. Alma Lasers is headquartered in Caesarea, Israel, with U.S. operations based in Fort Lauderdale, Florida.

Founded in 1968, TA Associates is one of the oldest and largest private equity firms in the world. Equipped with a $10 billion capital base, TA Associates invested in more than 360 companies and since 1995 have helped the firm’s portfolio companies to raise more than $15 billion.

Sponsored Links – Brain Games for Adults | Senior Alert Alarm